Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial

Kadriye Alpay, Mustafa Ertas, Elif Kocasoy Orhan, Didem Kanca Ustay, Camille Lieners, Betül Baykan, Kadriye Alpay, Mustafa Ertas, Elif Kocasoy Orhan, Didem Kanca Ustay, Camille Lieners, Betül Baykan

Abstract

Introduction: It is well-known that specific foods trigger migraine attacks in some patients. We aimed to investigate the effect of diet restriction, based on IgG antibodies against food antigens on the course of migraine attacks in this randomised, double blind, cross-over, headache-diary based trial on 30 patients diagnosed with migraine without aura.

Methods: Following a 6-week baseline, IgG antibodies against 266 food antigens were detected by ELISA. Then, the patients were randomised to a 6-week diet either excluding or including specific foods with raised IgG antibodies, individually. Following a 2-week diet-free interval after the first diet period, the same patients were given the opposite 6-week diet (provocation diet following elimination diet or vice versa). Patients and their physicians were blinded to IgG test results and the type of diet (provocation or elimination). Primary parameters were number of headache days and migraine attack count. Of 30 patients, 28 were female and 2 were male, aged 19-52 years (mean, 35 +/- 10 years).

Results: The average count of reactions with abnormally high titre was 24 +/- 11 against 266 foods. Compared to baseline, there was a statistically significant reduction in the number of headache days (from 10.5 +/- 4.4 to 7.5 +/- 3.7; P < 0.001) and number of migraine attacks (from 9.0 +/- 4.4 to 6.2 +/- 3.8; P < 0.001) in the elimination diet period.

Conclusion: This is the first randomised, cross-over study in migraineurs, showing that diet restriction based on IgG antibodies is an effective strategy in reducing the frequency of migraine attacks.

Figures

Figure 1.
Figure 1.
Cross-over design of the study.

References

    1. Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 2006; 27(Suppl 2): S107–S110
    1. Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR. CGRP and migraine; neurogenic inflammation revisited. J Headache Pain 2005; 6: 61–70
    1. Diamond S, Prager J, Freitag FG. Diet and headache Is there a link?. Postgrad Med J 1986; 79: 279–286
    1. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003; 28: 9–15
    1. Peatfield RC, Glover V, Littlewood JT, Sandler M, Clifford Rose F. The prevalence of diet-induced migraine. Cephalalgia 1984; 4: 179–183
    1. Peatfield RC. Relationships between food, wine, and beer-precipitated migrainous headaches. Headache 1995; 35: 355–357
    1. Savi L, Rainero I, Valfre W, Gentile S, Lo Giudice R, Pinessi L. Food and headache attacks. A comparison of patients with migraine and tension-type headache. Panminerva Med 2002; 44: 27–31
    1. Vaughan TR. The role of food in the pathogenesis of migraine headache. Clin Rev Allergy 1994; 12: 167–180
    1. Balyeat RM, Brittain FL. Allergic migraine: based on the study of fifty-five cases. Am J Med Sci 1930; 180: 212–221
    1. Sheldon JM, Randolph TG. Allergy in migraine-like headaches. Am J Med Sci 1935; 190: 232–236
    1. Heymann H. Migraine and food allergy, a survey of 20 cases. S Afr Med J 1952; 26: 949–950
    1. Speer F. Allergy and migraine: a clinical study. Headache 1971; 11: 63–67
    1. Egger J, Carter CM, Wilson J, Turner MW, Soothill JF. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet 1983; 2: 865–869
    1. Monro J, Carini C, Brostoff J. Migraine is a food-allergic disease. Lancet 1984; 2: 719–721
    1. Mansfield LE, Vaughan TR, Waller SF, Haverly RW, Ting S. Food allergy and adult migraine: double-blind and mediator confirmation of an allergic etiology. Ann Allergy 1985; 55: 126–129
    1. Halpern GM, Scott JR. Non-IgE antibody mediated mechanisms in food allergy. Ann Allergy 1987; 58: 14–27
    1. Aljada A, Mohanty P, Ghanim H, et al. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 2004; 79: 682–690
    1. Wilders-Truschnig M, Mangge H, Lieners C, Gruber H, Mayer C, Marz W. IgG antibodies against food antigens are correlated with inflammation and intima media thickness in obese juveniles. Exp Clin Endocrinol Diabetes 2008; 116: 241–245
    1. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 1459–1464
    1. Zar S, Mincher L, Benson MJ, Kumar D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005; 40: 800–807
    1. Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr 2006; 25: 514–522
    1. Zuo XL, Li YQ, Li WJ, et al. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin Exp Allergy 2007; 37: 823–830
    1. Rees T, Watson D. A prospective audit of food intolerance among migraine patients in primary care clinical practice. Headache Care 2005; 2: 11–14
    1. Arroyave Hernandez CM, Echevarria Pinto M, Hernandez Montiel HL. Food allergy mediated by IgG antibodies associated with migraine in adults. Rev Alerg Mex 2007; 54: 162–168
    1. Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low-fat diet on incidence and severity of migraine headaches. J Womens Health Gend Based Med 1999; 8: 623–630
    1. Bigal ME, Krymchantowski AV. Migraine triggered by sucralose – a case report. Headache 2006; 46: 515–517
    1. Patel RM, Sarma R, Grimsley E. Popular sweetner sucralose as a migraine trigger. Headache 2006; 46: 1303–1304
    1. Newman LC, Lipton RB. Migraine MLT-down: an unusual presentation of migraine in patients with aspartame-triggered headaches. Headache 2001; 41: 899–901
    1. Van den Eeden SK, Koepsell TD, Longstreth Jr WT, van Belle G, Daling JR, McKnight B. Aspartame ingestion and headaches: a randomized crossover trial. Neurology 1994; 44: 1787–1793
    1. Blau JN. Migraine triggers: practice and theory. Pathol Biol (Paris) 1992; 40: 367–372
    1. Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine, 2nd edition. Cephalalgia 2000; 20: 765–786
    1. Headache Classification Subcommittee of the International Headache Society The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24(Suppl 1): 9–160
    1. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 2007; 68: 1851–1861
    1. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006; 66: 545–550

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel